Erratum to: Cancer Chemother Pharmacol (2014) 73:1031–1039 DOI 10.1007/s00280-014-2438-4
The author would like to correct the errors in the publication of the original article. The corrected details are given below for your reading.
Page 1032, Subjects and methods, Study population: “body mass index of 18–33 kg/m [2], aged” should be replaced with “body mass index of 18–33 kg/m2, aged”.
Page 1033, Subjects and methods, Study design and treatment, Evaluation of lenalidomide interactions with temsirolimus: “serial blood samples were collected for 168-h after start of temsirolimus infusion” should be replaced with: “serial blood samples were collected in the first 168 h after start of temsirolimus infusion”.
Page 1033, Subjects and methods, Bioanalytical methodology: “tacrolimus, and [[13] C [2, 3] H7]-temsirolimus were” should be replaced with “tacrolimus, and [13C3, 2H7]-temsirolimus, were”.
Page 1034, Table 1: The text in the table should be aligned to the left.
The correct Table 1 is given below.
Page 1035, Figure 2A: “Quiridine” should be replaced with “Quinidine”.
Page 1035, Figure 2B: “Quiridine” should be replaced with “Sirolimus”.
The correct Fig. 2 is given below.
Page 1035, Figure 3B: “LEN + temsiroliums” should be replaced with “LEN + temsirolimus”.
The correct Fig. 3 is given below.
Page 1036, Figure 4, legend: “absence and presence of lenalidoimide” should be replaced with “absence or presence of lenalidomide”.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s00280-014-2438-4.
Rights and permissions
About this article
Cite this article
Chen, N., Weiss, D., Reyes, J. et al. Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers. Cancer Chemother Pharmacol 74, 659–660 (2014). https://doi.org/10.1007/s00280-014-2516-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-014-2516-7